Agilent Technologies, Inc. (A) Covered Calls

Agilent Technologies, Inc. is a global leader in life sciences, diagnostics, and applied chemical markets. Originally spun off from Hewlett-Packard, the company provides laboratories worldwide with analytical instruments, software, services, and consumables. Agilent’s solutions help scientists and clinicians advance research in areas such as drug discovery, food safety, environmental monitoring, and clinical diagnostics through high-precision measurement and data-driven insights.

You can sell covered calls on Agilent Technologies, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for A (prices last updated Mon 4:16 PM ET):

Want to make money with covered calls?  Sign Up For A Free Trial

Agilent Technologies operates as a premier provider of application-focused solutions that span the entire laboratory workflow. Its business model is organized into three primary segments: Life Sciences and Diagnostics, Applied Markets, and the Agilent CrossLab Group. The company provides a comprehensive suite of technologies, including liquid and gas chromatography, mass spectrometry, and genomics tools, which enable the identification and quantification of biological and chemical substances.

A core element of the firm’s strategy is its "software-plus-services" approach, captured largely within the Agilent CrossLab segment. This group provides high-margin consumables, maintenance, and cloud-based informatics that create deep operational lock-in with a global installed base of over 285,000 laboratories. By shifting toward an "integrated lab" model, Agilent leverages its "Ignite" operating system to drive execution excellence, helping customers automate sample preparation and data analysis to accelerate scientific discovery and improve diagnostic accuracy.

Competition

The life sciences and analytical instrument market is highly competitive, featuring large-scale diversified conglomerates and specialized technology providers. Agilent competes with entities that offer similar platforms for chromatography, mass spectrometry, and clinical diagnostics. Success in this sector requires significant and sustained investment in research and development, a robust global service network, and the ability to maintain stringent regulatory certifications across multiple international jurisdictions.

Key publicly traded, optionable competitors include Thermo Fisher Scientific Inc., Danaher Corporation, and Waters Corporation.

Strategic Outlook and Innovation

Agilent is focused on the "agentic" evolution of the laboratory, integrating artificial intelligence and machine learning into its software platforms to automate complex data interpretation. A primary strategic priority is the expansion of its presence in the biopharmaceutical and clinical markets, where demand for advanced cell analysis and protein characterization is increasing. The firm also emphasizes environmental sustainability, developing "green" laboratory solutions that reduce solvent consumption and energy usage during high-throughput testing.

Innovation is centered on the modernization of its digital ecosystem to facilitate remote laboratory management and real-time collaboration. By leveraging its expertise in vacuum technology and spectroscopy, the company seeks to enter new applied markets such as advanced materials and semiconductor manufacturing. The long-term vision remains focused on driving resilient growth through disciplined capital allocation, strategic tuck-in acquisitions, and the continued delivery of "trusted answers" that advance the quality of life globally.

Want more examples? AA Covered Calls